Abiomed Sales Boosted By Impella Reorders In Fiscal Q4
This article was originally published in The Gray Sheet
Executive Summary
Abiomed sales advanced 17% to $23 million for the most recent fiscal quarter, driven by Impella percutaneous cardiac assist system reorders, despite 68% slower growth in the customer base